Two-year follow-up of transcatheter aortic valve replacement in low-risk patients with symptomatic severe bicuspid aortic valve stenosis. (Record no. 14703)

MARC details
000 -LEADER
fixed length control field 03950nam a22005177a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 241030s20242024 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1522-1946
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 39109463
245 ## - TITLE STATEMENT
Title Two-year follow-up of transcatheter aortic valve replacement in low-risk patients with symptomatic severe bicuspid aortic valve stenosis.
251 ## - Source
Source Catheterization & Cardiovascular Interventions. 2024 Aug 07
252 ## - Abbreviated Source
Abbreviated source Catheter Cardiovasc Interv. 2024 Aug 07
253 ## - Journal Name
Journal name Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2024
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2025
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Publication date 2024 Aug 07
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status aheadofprint
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Medline status Publisher
266 ## - Date added to catalog
Date added to catalog 2024-10-30
266 ## - Date added to catalog
Date Medline record created 2024/08/07 05:33
501 ## - WITH NOTE
Local holdings Available online from MWHC library: 1996 - present, Available in print through MWHC library: 1996 - 2006
520 ## - SUMMARY, ETC.
Abstract BACKGROUND: In 2019, the US Food and Drug Administration (FDA) approved transcatheter aortic valve replacement (TAVR) for low-risk patients with symptomatic severe tricuspid aortic stenosis. However, bicuspid aortic valve (BAV) patients were included only in single-arm registries of pivotal low-risk TAVR trials, resulting in limited data for this subgroup.
520 ## - SUMMARY, ETC.
Abstract CONCLUSION: The 2-year follow-up confirms commendable clinical outcomes of TAVR in patients with bicuspid aortic stenosis, establishing its evident safety. Copyright © 2024 Wiley Periodicals LLC.
520 ## - SUMMARY, ETC.
Abstract METHODS: The LRT (Low Risk TAVR) trial was an investigator-initiated, prospective, multicenter study and the first FDA-approved investigational device exemption trial to evaluate the feasibility of TAVR with balloon-expandable or self-expanding valves in low-risk patients with symptomatic severe BAV stenosis. This analysis reports 2-year follow-up, assessing the primary outcome of all-cause mortality and evaluating clinical outcomes.
520 ## - SUMMARY, ETC.
Abstract RESULTS: From 2016 to 2019, a total of 72 low-risk patients diagnosed with symptomatic, severe BAV stenosis underwent TAVR across six centers. Six patients were lost to follow-up. At 2-year follow-up, mortality was 1.5% (1 of 66 patients). Among the remaining 65 patients, four experienced nondisabling strokes (6.2%), while 2 (3.1%) developed infective endocarditis. No new permanent pacemakers were required beyond the 30-day follow-up, and no patients, including those with endocarditis, needed aortic valve re-intervention. At the 2-year echocardiography follow-up (n = 65), 27.8% of BAV patients showed mild aortic regurgitation, with none exhibiting moderate or severe regurgitation. The mean aortic gradient was 12.1 +/- 4.1 mmHg, and the mean valve area was 1.7 +/- 0.5 cm2.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element IN PROCESS -- NOT YET INDEXED
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Heart & Vascular Institute
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Washington Hospital Center
656 ## - INDEX TERM--OCCUPATION
Department Advanced Cardiac Catheterization Research Fellowship
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Ben-Dor, Itsik
Institution Code MHVI
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Case, Brian C
Institution Code MHVI
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Merdler, Ilan
Institution Code MHVI
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Reddy, Pavan
Institution Code MWHC
Program Advanced Cardiac Catheterization Research Fellowship
Degree MD
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Rogers, Toby
Institution Code MHVI
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Satler, Lowell F
Institution Code MHVI
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Sawant, Vaishnavi
Institution Code MHVI
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Waksman, Ron
Institution Code MHVI
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Zhang, Cheng
Institution Code MHVI
790 ## - Authors
All authors Merdler I, Rogers T, Case BC, Zhang C, Gordon P, Ehsan A, Parikh P, Bilfinger T, Buchbinder M, Roberts D, Hanna N, Ben-Dor I, Reddy PK, Sawant V, Satler LF, Waksman R
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.1002/ccd.31170">https://dx.doi.org/10.1002/ccd.31170</a>
Public note https://dx.doi.org/10.1002/ccd.31170
858 ## - ORCID
ORCID text Satler, Lowell F
Orcid <a href="http://orcid.org/0000-0001-6446-2683">http://orcid.org/0000-0001-6446-2683</a>
Name http://orcid.org/0000-0001-6446-2683
858 ## - ORCID
ORCID text Waksman, Ron
Orcid <a href="http://orcid.org/0000-0002-4063-9226">http://orcid.org/0000-0002-4063-9226</a>
Name http://orcid.org/0000-0002-4063-9226
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
              10/30/2024   39109463 39109463 10/30/2024 10/30/2024 Journal Article

Powered by Koha